Xarelto Drug Lawsuits

Sponsored by Hissey-Kientz - Committed to protecting your legal rights.
Call us Toll Free at 866-275-4454 for a FREE Consultation
Help and information about Testosterone lawsuit issues.
Welcome

Problem with device in Xarelto trial dates back to 2002

April 5th, 2016

A device that was used in a prominent Xarelto study likely gave falsely low results in favor of the drug’s efficacy, and the problem with the device dates back to 2002. According to a study published by the editors of the British Medical Journal, the faulty device could have made Xarelto seem safer than it really is when it comes… read more »

Doctor says many colleagues hate Xarelto, other blood thinners

March 6th, 2016

The University of Pennsylvania Medical Center’s doctor Meriell Jessup told Reuters, ““I have many physicians, particularly surgeons, who hate [Xarelto and similar anticoagulants]; They’re frightened of them because they’ve had to deal with the consequences of somebody coming in with trauma.” The sentiments comes after hundreds of patients reported adverse Xarelto side effects after taking the blood thinner. read more »

Anticoagulant use on the rise

February 20th, 2016

Use of anticoagulants has been on the rise since blood thinners such as Xarelto were introduced to the market, according to a new study. In 2008, 51% of the patients eligible to be given a blood thinner (usually warfarin) took the drug. That number rose to61% in 2014 after the introductions of Pradaxa and Xarelto. read more »

Defective device may have skewed Xarelto study data

February 1st, 2016

The U.S. Food and Drug Administration and the European Medicines Agency are investigating whether a potentially defective blood-clotting test device skewered data in a Xarelto study. The possibility of a tainted study was first reported by the German newspaper Handelsblatt. read more »

Tests used to determine recent Xarelto bleeding risks may be unreliable

December 7th, 2015

Drug manufacturer Johnson & Johnson recently touted a study that found bleeding side effects from Xarelto are relatively uncommon, only occurring in about 7% of patients. However, a more recent study has found that the methods used to determine the risks of internal bleeding may be unreliable and doctors should monitor their patients closely for increased risks. read more »

Canada reviews link between Xarelto and liver complications

November 30th, 2015

Canadian health agency Health Canada launched a Xarelto investigation after 16 reports of liver damage related to the blood-thinning drug. At least 61 Canadian patients reported Xarelto liver damage and the World Health Organizations reported more than 430 cases of adverse events related to the liver and Xarelto use. read more »

Expensive blood thinner no more effective than cheap alternative, study says

November 23rd, 2015

A new study published in the New England Journal of Medicine has found that an expensive blood thinner is no more effective or safe than its much cheaper alternative. According to researchers, bivalirudin possesses no observable benefits over heparin despite being nearly 400 times as expensive. read more »

Xarelto not recommended for patients with kidney disease

November 16th, 2015

The Journal of the American Medical Association has released new guidelines stating that anti-coagulant drug Xarelto should not be used in patients with chronic kidney disease (CKD) including end-stage CKD. Xarelto is a blood thinner used to prevent blood clots and strokes in certain patients, though multiple reports claim Xarelto could increase the risk of adverse events, including blood clots… read more »

Increase in Xarelto sales linked to doctor with financial ties to drug manufacturer

September 5th, 2015

Sales of anti-bleeding drug Xarelto have increased recently thanks in large part to a doctor who has a history of receiving payments from Bayer HealthCare and other anticoagulant drug manufacturers. British heart doctor Gregory Lip has worked as a paid speaker and consultant to companies such as Bayer and received payments from 12 companies since 2006. Lip was reportedly at… read more »

Study finds Xarelto crosses into the placenta

August 30th, 2015

A new study presented at the Annual Scientific Meetings of the Canadian Society of Pharmacology and Therapeutics found that Xarelto (generic name rivaroxaban) is transferred rapidly through the placenta, both from mother to fetus and fetus to mother. The study is the first to show evidence that Xarelto diffuses through the placenta and may be unsafe for pregnant women. The… read more »

Contact Us Today for a Free Consultation.

I am currently represented by an attorney.
captcha
*Required fields